Il 1 Antagonists - Infectious Diseases

Relevant Publications

Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review.

Issue Release: 2024

Betahistine\'s Neuroprotective Actions against Lipopolysaccharide-Induced Neurotoxicity: Insights from Experimental and Computational Studies.

Issue Release: 2024

Autoantibody mediated Deficiency of IL-36-Receptor antagonist in a subset of patients with Psoriasis and Psoriatic Arthritis.

Issue Release: 2024

Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: A population-based study.

Issue Release: 2024

Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.

Issue Release: 2024

Interleukin-1 Blockers in Recurrent and Acute Pericarditis: State of the Art and Future Directions.

Issue Release: 2024

Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognition.

Issue Release: 2024

GLUT1 promotes NLRP3 inflammasome activation of airway epithelium in lipopolysaccharide-induced acute lung injury.

Issue Release: 2024

Epstein-Barr Virus Promotes Inflammatory Cytokine Production in Human Gingival Fibroblasts.

Issue Release: 2024

Study of IL-17 and Intercellular Adhesion Molecule-1 in Conjunctivochalasis Using Correlation Analysis.

Issue Release: 2024

Chemokine Receptor Antagonists Prevent and Reverse Cofilin-Actin Rod Pathology and Protect Synapses in Cultured Rodent and Human iPSC-Derived Neurons.

Issue Release: 2024

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.

Issue Release: 2024

Site-specific dimerization of interleukin-11 alleviates bleomycin-induced pulmonary fibrosis in mice.

Issue Release: 2024

Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-β Production through Its Interaction with AR/AR.

Issue Release: 2024

VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.

Issue Release: 2024

Adverse events of biologic or small molecule therapies in clinical trials for inflammatory bowel disease: A systematic review and meta-analysis.

Issue Release: 2024

Dupilumab as Add-on Therapy for Management of Chronic Spontaneous Urticaria.

Issue Release: 2024

Choosing immunomodulating therapies for the treatment of COVID-19: Recommendations based on placebo-controlled trial evidence.

Issue Release: 2024

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review.

Issue Release: 2024

Gastric digestion of the sweet-tasting plant protein thaumatin releases bitter peptides that reduce H. pylori induced pro-inflammatory IL-17A release via the TAS2R16 bitter taste receptor.

Issue Release: 2024

What Are the Challenges in Targeting Glycolysis?

How are Stool Samples Collected?

What are the guidelines for food safety?

What is the Prognosis for Ebola Patients?

What Research is Being Conducted on Apicoplasts?

How is Ebola Diagnosed?

What are the Common Imaging Tests?

What Types of Insect Repellents are Available?

What Role Do Public Health Organizations Play?

When Should Stool Samples be Collected?

Partnered Content Networks

Relevant Topics